companydata.dkcompanydata.dk

PEAK BIOTECH A/S: Financial statements 2024

CVR: 28892152

Source: annual report 2024, Danish Business Authority

01/07/2023 – 30/06/2024

PEAK BIOTECH A/S (CVR 28892152) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 22,438,947 and a net result of DKK 16,506,232 compared with DKK 3,374,405 the year before. That is an increase of 178.9% compared with the year before. Equity in the 2024 report amounted to DKK 22,133,267. The solvency ratio was 45.4%.

Gross Profit
DKK 22,438,947
Profit/Loss
DKK 16,506,232
Equity
DKK 22,133,267
Total Assets
DKK 48,718,765

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-22.4 mio.16.5 mio.22.1 mio.-
2023-8 mio.3.4 mio.13.6 mio.4
2022-8.8 mio.4.7 mio.10.7 mio.4
2021-9.1 mio.5.1 mio.11 mio.3
2020-10.4 mio.6.2 mio.10.4 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

About PEAK BIOTECH A/S

PEAK BIOTECH A/S is a Danish company of the type Aktieselskab based in Kvistgård, founded in 2005. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Kim Gejl Vind. The board consists of Jens Ulrik Damgaard (chair), Jacob Nøhr and Kim Gejl Vind. The company is owned by BIOTECH HOLDING ApS and PEAK HOLDING ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 29,437,632 and a net result of DKK 21,861,113 compared with DKK 16,506,232 the year before. Equity in the 2025 report amounted to DKK 43,994,380.

Source: annual report 2025, Danish Business Authority